Emergent BioSolutions (EBS) Enterprise Value Growth (3y) (2013 - 2026)
Emergent BioSolutions (EBS) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Emergent BioSolutions | 261.35 Mn | 120.45 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.72% |
| Mar 31, 2026 | 27.86% |
| Dec 31, 2025 | 31.22% |
| Sep 30, 2025 | -1.12% |
| Jun 30, 2025 | 8.89% |
| Mar 31, 2025 | 29.50% |
| Dec 31, 2024 | 43.20% |
| Sep 30, 2024 | 27.12% |
| Jun 30, 2024 | 45.87% |
| Mar 31, 2024 | 47.57% |
| Dec 31, 2023 | 43.57% |
| Sep 30, 2023 | 40.42% |
| Jun 30, 2023 | 30.94% |
| Mar 31, 2023 | -33.28% |
| Dec 31, 2022 | -56.39% |
| Sep 30, 2022 | -964.13% |
| Jun 30, 2022 | -1,114.52% |
| Mar 31, 2022 | -47.02% |
| Dec 31, 2021 | -72.44% |
| Sep 30, 2021 | -5.98% |